// App-Quantinova.ai

: Kinetics of BCR-ABL after TKI Interruption during Pregnancy in CML: A Multinational Retrospective Analysis

Researchers

Presenter

  • Jeong-Ok Lee

Principal Investigators

  • Dong-Wook Kim

  • Elisabetta Abruzzese

  • Jane Apperley

  • Louise Caldwell

  • Michael J. Mauro

Medical Centers

  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)

  • Department of Hematology, Catholic Blood and Marrow Transplantation Center, Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

  • Hematology, S.Eugenio Hospital, Rome, Italy

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

  • Medical School, University of Birmingham, Sheffield, United Kingdom

  • Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York

Locations

  • Republic of South Korea

  • Italy

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved